Aytar Çelik Pınar, Erdogan-Gover Kubra, Barut Dilan, Enuh Blaise Manga, Amasya Gülin, Sengel-Türk Ceyda Tuba, Derkus Burak, Çabuk Ahmet
Environmental Protection and Control Program, Eskisehir Osmangazi University, Eskisehir 26110, Turkey.
Department of Biotechnology and Biosafety, Graduate School of Natural and Applied Science, Eskisehir Osmangazi University, Eskisehir 26040, Turkey.
Pharmaceutics. 2023 Mar 24;15(4):1052. doi: 10.3390/pharmaceutics15041052.
Bacterial membrane vesicles (BMVs) are known to be critical communication tools in several pathophysiological processes between bacteria and host cells. Given this situation, BMVs for transporting and delivering exogenous therapeutic cargoes have been inspiring as promising platforms for developing smart drug delivery systems (SDDSs). In the first section of this review paper, starting with an introduction to pharmaceutical technology and nanotechnology, we delve into the design and classification of SDDSs. We discuss the characteristics of BMVs including their size, shape, charge, effective production and purification techniques, and the different methods used for cargo loading and drug encapsulation. We also shed light on the drug release mechanism, the design of BMVs as smart carriers, and recent remarkable findings on the potential of BMVs for anticancer and antimicrobial therapy. Furthermore, this review covers the safety of BMVs and the challenges that need to be overcome for clinical use. Finally, we discuss the recent advancements and prospects for BMVs as SDDSs and highlight their potential in revolutionizing the fields of nanomedicine and drug delivery. In conclusion, this review paper aims to provide a comprehensive overview of the state-of-the-art field of BMVs as SDDSs, encompassing their design, composition, fabrication, purification, and characterization, as well as the various strategies used for targeted delivery. Considering this information, the aim of this review is to provide researchers in the field with a comprehensive understanding of the current state of BMVs as SDDSs, enabling them to identify critical gaps and formulate new hypotheses to accelerate the progress of the field.
细菌膜泡(BMVs)是细菌与宿主细胞之间多种病理生理过程中的关键通讯工具。鉴于此,用于运输和递送外源性治疗性货物的BMVs作为开发智能药物递送系统(SDDSs)的有前景平台,一直备受鼓舞。在本综述文章的第一部分,我们从介绍制药技术和纳米技术入手,深入探讨了SDDSs的设计和分类。我们讨论了BMVs的特性,包括其大小、形状、电荷、有效的生产和纯化技术,以及用于货物装载和药物封装的不同方法。我们还阐明了药物释放机制、作为智能载体的BMVs的设计,以及关于BMVs在抗癌和抗菌治疗潜力方面的最新显著发现。此外,本综述涵盖了BMVs的安全性以及临床应用需要克服的挑战。最后,我们讨论了BMVs作为SDDSs的最新进展和前景,并强调了它们在革新纳米医学和药物递送领域的潜力。总之,本综述文章旨在全面概述BMVs作为SDDSs的前沿领域,包括它们的设计、组成、制造、纯化和表征,以及用于靶向递送的各种策略。考虑到这些信息,本综述的目的是让该领域的研究人员全面了解BMVs作为SDDSs的当前状态,使他们能够识别关键差距并提出新的假设,以加速该领域的进展。